Baudax Bio Inc
Biotechnology
Healthcare
BXRX
300 shares
NASDAQ US
traded
26 Apr 2023
listed
yes
open
1.73
52 week high
24.76
high
1.85
52 week low
1.33
low
1.45
growth
22.92 %
previous Close
2.09
P/E ratio
-0
market cap
4.47 M
div yield
0
usd
Dec 2022
qoq
revenue
309 K
29.83 %
net incoming
-9.25 M
68.33 %
eps
-12.33 %
87.52 %
eps surprise
-26.33 %
net profit margin
-2993.53 %
9277.00 %
operating incoming
-8.60 M
70.03 %
net change in cash
-388.00 K
-188.79 %
cash on hand
5.26 M
-6.87 %
cost of revenue
4.79 M
296.69 %
top top